Vanguard Group Inc Anebulo Pharmaceuticals, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Anebulo Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 154,036 shares of ANEB stock, worth $194,085. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,036
Previous 154,036
-0.0%
Holding current value
$194,085
Previous $297,000
13.13%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ANEB
# of Institutions
16Shares Held
22.6MCall Options Held
0Put Options Held
0-
22 Nw, LP Seattle, WA15.5MShares$19.5 Million21.77% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.04MShares$3.83 Million0.26% of portfolio
-
Mangrove Partners New York, NY2.53MShares$3.18 Million0.66% of portfolio
-
Lvw Advisors, LLC633KShares$796,9700.13% of portfolio
-
Morgan Stanley New York, NY420KShares$529,1920.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $32.3M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...